Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Real World Performance of SARS-CoV-2 Antigen Rapid Diagnostic Tests in Various Clinical Settings

Gili Regev-Yochay, Or Kriger, Sharon Beni, Carmit Rubin, Michael J. Mina, Bella Mechnik, Sabrina Hason, Elad Biber, Bian Nadaf, Yitshak Kreiss, Sharon Amit
doi: https://doi.org/10.1101/2021.03.02.21252400
Gili Regev-Yochay
1Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer, Israel
2Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gili.regev@sheba.health.gov.il
Or Kriger
3Clinical Microbiology, Sheba Medical Center, Tel Hashomer, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharon Beni
1Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carmit Rubin
1Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Mina
4Harvard Chan School of Public Health, Harvard, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bella Mechnik
1Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sabrina Hason
1Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elad Biber
1Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bian Nadaf
1Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yitshak Kreiss
5Central Management, Sheba Medical Center, Tel Hashomer, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharon Amit
3Clinical Microbiology, Sheba Medical Center, Tel Hashomer, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Several uses of Antigen rapid diagnostic tests (Ag-RDT) have been suggested. Analytical studies reported high specificity yet with lower sensitivity for detecting SARS-CoV-2 compared to qRT-PCR. Here, we present the use of these tests as a decision support tool in several settings.

Methods Samples were collected for both Ag-RDT and qRT-PCR in three different clinical settings; 1. Symptomatic patients presenting at the Emergency Departments 2. Asymptomatic patients screened upon hospitalization and 3. Health-care workers (HCW) following SARS-CoV-2 exposure. Positive percent agreement (PPA), negative percent agreement (NPA), positive predictive value (PPV) and negative predictive value (NPV) were calculated. To estimate the association between Ct value, Ag-RDT and the number of days since SARS-CoV-2 exposure or symptomatic COVID-19, a mixed model was applied.

Results A total of 5172 samples were obtained from 4595 individuals, with Ag-RDT and qRT-PCR results. Of these, 485 samples were positive by qRT-PCR. The PPA of Ag-RDT was greater for lower Ct values, reaching 93% in cases where Ct value was lower than 25 and 85% where Ct value was lower than 30. PPA was similar between symptomatic and asymptomatic individuals. The NPV and PPV were 96.8% and 99.1%, respectively. We observed a significant correlation between Ct value and time from infection onset (p<0.001). Lower Ct values were significantly associated with a positive Ag-RDT (p=0.01).

Conclusions Ag-RDT can be used as a decision support tool in various clinical settings and play a major role in early detection of SARS-CoV-2 infected individuals, highly specific and with high sensitivity to the infectious stage of disease, whether symptomatic or asymptomatic.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No external funding resources were available

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Sheba Medical Center IRB committee

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data is available at Sheba Medical Center

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 05, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Real World Performance of SARS-CoV-2 Antigen Rapid Diagnostic Tests in Various Clinical Settings
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Real World Performance of SARS-CoV-2 Antigen Rapid Diagnostic Tests in Various Clinical Settings
Gili Regev-Yochay, Or Kriger, Sharon Beni, Carmit Rubin, Michael J. Mina, Bella Mechnik, Sabrina Hason, Elad Biber, Bian Nadaf, Yitshak Kreiss, Sharon Amit
medRxiv 2021.03.02.21252400; doi: https://doi.org/10.1101/2021.03.02.21252400
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Real World Performance of SARS-CoV-2 Antigen Rapid Diagnostic Tests in Various Clinical Settings
Gili Regev-Yochay, Or Kriger, Sharon Beni, Carmit Rubin, Michael J. Mina, Bella Mechnik, Sabrina Hason, Elad Biber, Bian Nadaf, Yitshak Kreiss, Sharon Amit
medRxiv 2021.03.02.21252400; doi: https://doi.org/10.1101/2021.03.02.21252400

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (270)
  • Allergy and Immunology (552)
  • Anesthesia (135)
  • Cardiovascular Medicine (1760)
  • Dentistry and Oral Medicine (238)
  • Dermatology (173)
  • Emergency Medicine (312)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (659)
  • Epidemiology (10799)
  • Forensic Medicine (8)
  • Gastroenterology (592)
  • Genetic and Genomic Medicine (2950)
  • Geriatric Medicine (287)
  • Health Economics (534)
  • Health Informatics (1928)
  • Health Policy (836)
  • Health Systems and Quality Improvement (745)
  • Hematology (292)
  • HIV/AIDS (630)
  • Infectious Diseases (except HIV/AIDS) (12518)
  • Intensive Care and Critical Care Medicine (692)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (324)
  • Neurology (2799)
  • Nursing (151)
  • Nutrition (433)
  • Obstetrics and Gynecology (559)
  • Occupational and Environmental Health (597)
  • Oncology (1467)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (257)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (381)
  • Pediatrics (866)
  • Pharmacology and Therapeutics (366)
  • Primary Care Research (337)
  • Psychiatry and Clinical Psychology (2640)
  • Public and Global Health (5370)
  • Radiology and Imaging (1013)
  • Rehabilitation Medicine and Physical Therapy (596)
  • Respiratory Medicine (726)
  • Rheumatology (330)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (279)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (150)
  • Urology (125)